AirSculpt Technologies, Inc. reported a slight increase in revenue for the first quarter of 2026, generating $39.4 million compared to $39.4 million in the same period of 2025. The company performed 3,082 cases during the quarter, a marginal increase from 3,076 cases year-over-year. Despite the flat revenue, the company experienced a net loss of $2.4 million, an improvement from a net loss of $2.8 million in the prior year. The loss per share was $(0.03), compared to $(0.05) in the same quarter of 2025.
Operating expenses rose to $41.2 million, up from $41.0 million in the previous year, primarily driven by a $0.8 million increase in selling, general, and administrative expenses. This increase was attributed to higher professional service fees and advertising costs, which were partially offset by a decrease in stock compensation expenses. The cost of services decreased slightly to $15.6 million, representing 39.6% of revenue, down from 40.5% in the prior year. The company’s interest expense also decreased to $1.2 million from $1.6 million, reflecting principal prepayments on its debt.
In terms of strategic developments, AirSculpt expanded its operational footprint, now operating 31 centers across 20 states and Canada. The company successfully raised approximately $14.6 million through an at-the-market offering program, selling 5.9 million shares. This capital infusion was utilized to prepay $10 million of its term loan, reducing its total debt to $44.8 million as of March 31, 2026. The company’s cash and cash equivalents increased to $16.7 million, compared to $5.6 million at the same time last year.
AirSculpt's operational metrics indicate a stable performance, with a slight increase in same-center cases and revenue growth. The company reported a working capital deficit of $8.2 million, an improvement from $12.4 million at the end of 2025. The company continues to focus on enhancing its marketing strategies and optimizing its operational efficiencies to drive future growth.
Looking ahead, AirSculpt remains cautious about market conditions and competition in the weight loss and obesity solutions market. The company is committed to addressing its internal control weaknesses and enhancing its financial reporting processes. Management believes that the cash generated from operations will be sufficient to meet its working capital needs and liquidity obligations for at least the next 12 months, although it acknowledges the potential challenges in refinancing its debt obligations as they come due.
About Airsculpt Technologies, Inc.
AirSculpt Technologies, Inc. specializes in minimally invasive body contouring procedures that remove fat and tighten skin without needles, scalpels, stitches, or general anesthesia. Its proprietary AirSculpt® method offers customized fat removal and fat transfer treatments, including the Power BBL®, Up a Cup™, and Hip Flip®. Serving primarily affluent metropolitan and suburban markets across the U.S., Canada, and the U.K., AirSculpt delivers premium patient experiences through surgeon-led care in spa-like centers, operating on a private-pay, scalable business model.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.